相似文献
1
Formulation and Delivery Technologies for mRNA Vaccines.
Curr Top Microbiol Immunol. 2022;440:71-110. doi: 10.1007/82_2020_217.
2
The Delivery of mRNA Vaccines for Therapeutics.
Life (Basel). 2022 Aug 17;12(8):1254. doi: 10.3390/life12081254.
3
mRNA vaccines and their delivery strategies: A journey from infectious diseases to cancer.
Mol Ther. 2024 Jan 3;32(1):13-31. doi: 10.1016/j.ymthe.2023.10.024. Epub 2023 Nov 3.
4
The clinical progress and challenges of mRNA vaccines.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Sep-Oct;15(5):e1894. doi: 10.1002/wnan.1894. Epub 2023 Apr 24.
5
[New Hopes in Vaccine Technology: mRNA Vaccines].
Mikrobiyol Bul. 2021 Apr;55(2):265-284. doi: 10.5578/mb.20219912.
6
mRNA vaccine designs for optimal adjuvanticity and delivery.
RNA Biol. 2024 Jan;21(1):1-27. doi: 10.1080/15476286.2024.2333123. Epub 2024 Mar 26.
7
Delivery Strategies for mRNA Vaccines.
Pharmaceut Med. 2022 Feb;36(1):11-20. doi: 10.1007/s40290-021-00417-5. Epub 2022 Jan 30.
8
Current Developments and Challenges of mRNA Vaccines.
Annu Rev Biomed Eng. 2022 Jun 6;24:85-109. doi: 10.1146/annurev-bioeng-110220-031722. Epub 2022 Mar 1.
9
[mRNA vaccines for infectious diseases: research progress and applications].
Sheng Wu Gong Cheng Xue Bao. 2023 Oct 25;39(10):3966-3984. doi: 10.13345/j.cjb.230273.
10
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.
Mol Ther. 2019 Apr 10;27(4):757-772. doi: 10.1016/j.ymthe.2019.01.020. Epub 2019 Feb 7.
引用本文的文献
1
Freeze-Drying of mRNA-LNPs Vaccines: A Review.
Vaccines (Basel). 2025 Aug 12;13(8):853. doi: 10.3390/vaccines13080853.
2
Research progress of mRNA vaccines for infectious diseases.
Eur J Med Res. 2025 Aug 23;30(1):792. doi: 10.1186/s40001-025-03060-x.
3
production of CAR T cell: Opportunities and challenges.
Genes Dis. 2025 Mar 25;12(6):101612. doi: 10.1016/j.gendis.2025.101612. eCollection 2025 Nov.
4
Transfection Technologies for Next-Generation Therapies.
J Clin Med. 2025 Aug 5;14(15):5515. doi: 10.3390/jcm14155515.
5
Nanotechnology-based mRNA vaccines.
Nat Rev Methods Primers. 2023;3(1). doi: 10.1038/s43586-023-00246-7. Epub 2023 Aug 17.
6
Immunogenicity of DNA, mRNA and Subunit Vaccines Against Beak and Feather Disease Virus.
Vaccines (Basel). 2025 Jul 17;13(7):762. doi: 10.3390/vaccines13070762.
7
Rationally designed self-assembled peptide nanofibers provoke robust humoral immunity against nervous necrosis virus.
J Virol. 2025 Aug 19;99(8):e0031925. doi: 10.1128/jvi.00319-25. Epub 2025 Jul 15.
8
Advances and challenges in cancer immunotherapy: mechanisms, clinical applications, and future directions.
Front Pharmacol. 2025 Jun 13;16:1602529. doi: 10.3389/fphar.2025.1602529. eCollection 2025.
9
mRNA Vaccine Technology Beyond COVID-19.
Vaccines (Basel). 2025 May 31;13(6):601. doi: 10.3390/vaccines13060601.
10
mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy.
Front Bioeng Biotechnol. 2025 Mar 12;13:1547025. doi: 10.3389/fbioe.2025.1547025. eCollection 2025.
本文引用的文献
1
Peptide-based gene delivery vectors.
J Mater Chem B. 2019 Mar 21;7(11):1824-1841. doi: 10.1039/c8tb03124j. Epub 2019 Feb 15.
2
Recent advances in mRNA vaccine technology.
Curr Opin Immunol. 2020 Aug;65:14-20. doi: 10.1016/j.coi.2020.01.008. Epub 2020 Mar 31.
3
The challenge and prospect of mRNA therapeutics landscape.
Biotechnol Adv. 2020 May-Jun;40:107534. doi: 10.1016/j.biotechadv.2020.107534. Epub 2020 Feb 21.
4
Sugar-Nanocapsules Imprinted with Microbial Molecular Patterns for mRNA Vaccination.
Nano Lett. 2020 Mar 11;20(3):1499-1509. doi: 10.1021/acs.nanolett.9b03483. Epub 2020 Feb 10.
5
Aerosol Delivery of Synthetic mRNA to Vaginal Mucosa Leads to Durable Expression of Broadly Neutralizing Antibodies against HIV.
Mol Ther. 2020 Mar 4;28(3):805-819. doi: 10.1016/j.ymthe.2020.01.002. Epub 2020 Jan 10.
6
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering.
Nano Lett. 2020 Mar 11;20(3):1578-1589. doi: 10.1021/acs.nanolett.9b04246. Epub 2020 Feb 5.
7
Engineering dendritic cell vaccines to improve cancer immunotherapy.
Nat Commun. 2019 Nov 27;10(1):5408. doi: 10.1038/s41467-019-13368-y.
8
Nasal route for vaccine and drug delivery: Features and current opportunities.
Int J Pharm. 2019 Dec 15;572:118813. doi: 10.1016/j.ijpharm.2019.118813. Epub 2019 Oct 31.
9
Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation.
Nat Biotechnol. 2019 Oct;37(10):1174-1185. doi: 10.1038/s41587-019-0247-3. Epub 2019 Sep 30.
10
Lipid-based nanoparticle formulations for small molecules and RNA drugs.
Expert Opin Drug Deliv. 2019 Nov;16(11):1205-1226. doi: 10.1080/17425247.2019.1669558.
Zotero 插件